Medtronic stays on track with expanded DES (drug-eluting stent) trial
This article was originally published in Clinica
Executive Summary
In a move that it claims keeps it on track with its drug-eluting stent (DES) launch timelines, Medtronic has broadened its clinical trial programme in Europe to increase patient exposure to its Endeavor stent.